Budesonide And Formoterol Fumarate Dihydrate
Product Images NDC 53002-2667

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Budesonide And Formoterol Fumarate Dihydrate (NDC 53002-2667). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Counter Image 15 (308708 Rapihaler Counter 15 (black;130;485))

FDA Label Image

Counter Image 80 (308710 Rapihaler Counter 80 (black;130;485))

FDA Label Image

Figure 1 (Figure1bodytext)

This appears to be a table showing the results of a study or experiment involving the use of different medications for treatment. The medications listed include Budesonide and Formoterol Fumarate Dihydrate, Budesonide, Formoterol, and a Placebo. The table shows numerical data for each of the medications tested. However, there is not enough context to determine the purpose of the study or the conditions under which the medications were administered.*

FDA Label Image

Figure 2 (Figure2bodytext)

FDA Label Image

Figure 3 (Figure3bodytext)

FDA Label Image

Figure 4 (Figure4bodytext)

FDA Label Image

Figure 5 (Figure5bodytext)

FDA Label Image

Figure 6 (Figure6bodytext)

This is a description of a study evaluating the efficacy of various medications in improving pre-dose FEV (forced expiratory volume) compared to baseline. The medications evaluated were Budenoside and Formoterol, each administered separately and as a combination, and a placebo. Results of the study are presented in a table with numerical values representing the change in the FEV.*

FDA Label Image

Figure 7 (Figure7bodytext)

This is a table that shows the percent change from the baseline in 1-hour post-dose FEV. The table compares the results for different types of medication, including Budesonide and Formoterol Fumarate Dihydrate MDI, Budesonide, Formoterol, Budesonide + Formoterol, and Placebo. The medication is taken via inhalation, with two inhalations twice daily. The data is organized by month, with the end of treatment also included.*

FDA Label Image

Budesonide Structural Formula (Image 01)

FDA Label Image

Structural Fumarate (Image 02)

FDA Label Image

Figure 1 (Image 03)

This appears to be a diagram or illustration of a device called "Counter". It shows a canister with water inside, a mouthpiece, a strap, and a cover for the mouthpiece. Beyond that, without any additional context or information, it is unclear what the Counter device is for, how it is used, or what purpose it serves.*

FDA Label Image

Figure 2 Gray Arrows (Image 04)

FDA Label Image

Figure 3 (Image 05)

FDA Label Image

Figure 4 (Image 06)

FDA Label Image

Figure 5 (Image 07)

FDA Label Image

Label Image (Lbl530022667)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.